CD36 gene polymorphism is associated with Alzheimer's disease

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• CD36 gene encodes a scavenger receptor with diverse cellular functions.
• Alzheimer's disease (AD) is a complex neurodegenerative disorder with genetic risk factors.
• Previous studies identified ApoE gene variants associated with AD risk.

Purpose of the Study:

• To investigate the association between CD36 gene polymorphisms and Alzheimer's disease risk.
• To validate ApoE gene associations in the study cohort.
• To explore potential mechanisms linking CD36 variants to AD pathogenesis.

Main Methods:

• Case-control genetic association study.
• Analysis of single nucleotide polymorphisms (SNPs) in CD36 and ApoE genes.
• Recruitment of 859 Alzheimer's disease patients and control subjects.

Main Results:

• The allele A in CD36 gene polymorphism rs3211892 was significantly associated with increased AD risk.
• Confirmed previously reported associations between ApoE SNPs and AD risk/age of onset.
• Identified a novel association between CD36 gene variations and Alzheimer's disease.

Conclusions:

• CD36 gene variations, specifically rs3211892, represent a novel risk factor for Alzheimer's disease.
• Proposed mechanisms include altered cholesterol homeostasis, oxidative stress, or inflammatory cascades.
• This study underscores the importance of CD36 in AD etiology.